(Q64336187)

English

ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

PREDICT-DGF (English)

0 references

title

Prospective Multicentric, Randomized, Open-labeled, in Parallel Groups, Study to Assess the Benefit/Risk of an Induction Treatment With Anti-Thymocyte Globulins (ATG) Versus Basiliximab in Kidney Transplant Patients Displaying Low Immunological Risk But High Susceptibility to Delayed Graft Function. (English)

0 references

medical condition

delayed graft function

0 references

country

France

0 references

start time

June 2014

0 references

end time

February 2017